Stay updated on Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a new version of the page template or underlying system has been applied to the study details page. This update appears to affect the page version rather than the study data itself.
    Difference
    0.0%
    Check dated 2026-07-04T04:24:10.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2, indicating a minor page update. There is no evidence that study data or visible content has changed.
    Difference
    0.0%
    Check dated 2026-06-27T02:41:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    New navigation and help sections were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was updated. The revision tag was updated to Revision: v3.6.0 and the older Revision: v3.5.5 note was removed.
    Difference
    0.4%
    Check dated 2026-06-12T16:38:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a maintenance update to the page without described user-facing changes.
    Difference
    0.1%
    Check dated 2026-06-05T12:31:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page footer displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates the page content has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-05-15T04:50:33.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, representing a newer version of the ClinicalTrials.gov page. There are no changes described to the study details, eligibility, or outcomes in this change.
    Difference
    0.1%
    Check dated 2026-04-30T18:30:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.